Search

Search Constraints

You searched for: Author/Creator Anderson, Peter L

Search Results

2. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Issue 1 (January 2019)

3. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report. Issue 11 (November 2017)

4. Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study. (19th November 2020)

5. Adherence to event‐driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3‐monthly questionnaires and intracellular TFV‐DP. Issue 5 (10th May 2021)

6. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial. Issue 10 (October 2022)

7. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial. (24th June 2021)

8. Associations Between Tenofovir Diphosphate in Dried Blood Spots, Impaired Physical Function, and Fracture Risk. (27th November 2020)

9. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Issue 10337 (7th May 2022)

10. Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113. (8th June 2019)